Pamukcu Rifat (CIK 1929298) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-17). Recent activity: Buy APRE (3,135 shares), Buy APRE (1,045 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | Aprea Therapeutics, Inc. (APRE) | Director | Buy | 3,135 | $0 |
| 2025-06-09 | Aprea Therapeutics, Inc. (APRE) | Director | Buy | 1,045 | $0 |
Source: SEC Form 4 filings · as of 2026-06-17